Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (37)

« Back to Publications

Longitudinal trajectories of polypharmacy in older people, and their association with the risk of mortality: a joint latent class model analysis of real-world data from the UK and the Netherlands.

Elhussein L. et al, (2025), Age Ageing, 54

Longitudinal trajectories of health indicators using real world data

Elhussein L., (2025)

Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial.

Scanlon E. et al, (2024), ESMO Open, 9

Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of Fluoroquinolones.

Guo Y. et al, (2024), Pharmacoepidemiol Drug Saf, 33

Longitudinal trajectories of frailty are associated with short-term mortality in older people: a joint latent class models analysis using 2 UK primary care databases.

Elhussein L. et al, (2024), J Clin Epidemiol, 173

Incidence and Complications of Rectopexy in the United Kingdom and United States, 2013-2022

Corby G. et al, (2024), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 33, 395 - 395

Prevalence of Dermatomyositis and Polymyositis in Adults and Paediatric Populations: A Network Cohort Study Part of DARWIN EU®

Prats-Uribe A. et al, (2024), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 33, 156 - 157

Use of Systemic Fluoroquinolones in Primary Care and Hospital Settings in the UK: A Population-Level Cohort Study

Elhussein L. et al, (2024), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 33, 283 - 283

Natural History of Dermatomyositis and Polymyositis in Adults and Paediatric Populations: A Network Cohort Study Part of DARWIN EU®

Lopez-Guell K. et al, (2024), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 33, 326 - 326

PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer.

Woodcock VK. et al, (2023), BJUI Compass, 4, 322 - 330

Characterising complex health needs and the use of preventive therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data.

Elhussein L. et al, (2023), BMC Geriatr, 23

Redefining polypharmacy in older people taking into account longitudinality: A joint latent class analysis

Elhussein LME. et al, (2023), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 32, 466 - 466

Estimating the Incidence and Key Risk Factors of Cardiovascular Disease in Patients at High Risk of Imminent Fracture Using Routinely Collected Real-World Data From the UK.

Pineda-Moncusí M. et al, (2022), J Bone Miner Res, 37, 1986 - 1996

Characterising complex health needs and the use of preventative therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data

Elhussein L. et al, (2022)

Longitudinal progression of frailty in older population and risk of mortality: An application of joint latent class models

Elhussein LME. et al, (2022), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 31, 300 - 300

Load More